These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 9565715

  • 1. Fluoxetine in depressed patients on dialysis.
    Blumenfield M, Levy NB, Spinowitz B, Charytan C, Beasley CM, Dubey AK, Solomon RJ, Todd R, Goodman A, Bergstrom RF.
    Int J Psychiatry Med; 1997; 27(1):71-80. PubMed ID: 9565715
    [Abstract] [Full Text] [Related]

  • 2. Fluoxetine in depressed patients with renal failure and in depressed patients with normal kidney function.
    Levy NB, Blumenfield M, Beasley CM, Dubey AK, Solomon RJ, Todd R, Goodman A, Bergstrom RR.
    Gen Hosp Psychiatry; 1996 Jan; 18(1):8-13. PubMed ID: 8666216
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression.
    Abolfazli R, Hosseini M, Ghanizadeh A, Ghaleiha A, Tabrizi M, Raznahan M, Golalizadeh M, Akhondzadeh S.
    Depress Anxiety; 2011 Apr; 28(4):297-302. PubMed ID: 21456039
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB, Farabaugh A, Johnson MW, Morray M, Delgado ML, Pingol MG, Rosenbaum JF, Fava M.
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
    Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A.
    Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fluoxetine in medically stable, depressed geriatric patients: effects on weight.
    Goldstein DJ, Hamilton SH, Masica DN, Beasley CM.
    J Clin Psychopharmacol; 1997 Oct; 17(5):365-9. PubMed ID: 9315987
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of High-Dose Supplementation With Oral Vitamin D3 on Depressive Symptoms in Dialysis Patients With Vitamin D3 Insufficiency: A Prospective, Randomized, Double-Blind Study.
    Wang Y, Liu Y, Lian Y, Li N, Liu H, Li G.
    J Clin Psychopharmacol; 2016 Jun; 36(3):229-35. PubMed ID: 27022679
    [Abstract] [Full Text] [Related]

  • 13. Unsuspected poor metabolizer phenotypes of fluoxetine in bioavailability/bioequivalence studies from an indian population perspective. Retrospective pharmacokinetic data evaluation.
    Kandasamy M, Tripathy K, Ravi S, Kamath N, Pai B, Srinivas NR, Kristjansson F, Thangam S.
    Arzneimittelforschung; 2010 Jun; 60(1):12-21. PubMed ID: 20184222
    [Abstract] [Full Text] [Related]

  • 14. Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot study.
    Heiligenstein JH, Hoog SL, Wagner KD, Findling RL, Galil N, Kaplan S, Busner J, Nilsson ME, Brown EB, Jacobson JG.
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(1-2):207-17. PubMed ID: 16553541
    [Abstract] [Full Text] [Related]

  • 15. The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine.
    Papakostas GI, Petersen T, Lebowitz BD, Mischoulon D, Ryan JL, Nierenberg AA, Bottiglieri T, Alpert JE, Rosenbaum JF, Fava M.
    Int J Neuropsychopharmacol; 2005 Dec; 8(4):523-8. PubMed ID: 15877935
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P, Baker B, Irvine J, Dorian P, McKessok D, Mendlowitz S.
    Depress Anxiety; 1998 Dec; 7(2):69-72. PubMed ID: 9614594
    [Abstract] [Full Text] [Related]

  • 17. [Toxic tricyclic drug plasma level caused by fluoxetine].
    Hambrecht M.
    Psychiatr Prax; 1995 Nov; 22(6):252-3. PubMed ID: 8570758
    [Abstract] [Full Text] [Related]

  • 18. Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse.
    Iovieno N, van Nieuwenhuizen A, Clain A, Baer L, Nierenberg AA.
    Depress Anxiety; 2011 Feb; 28(2):137-44. PubMed ID: 21284066
    [Abstract] [Full Text] [Related]

  • 19. Personality traits and recovery from major depressive disorder.
    Kronström K, Salminen JK, Hietala J, Kajander J, Vahlberg T, Markkula J, Rasi-Hakala H, Karlsson H.
    Nord J Psychiatry; 2011 Feb; 65(1):52-7. PubMed ID: 20500120
    [Abstract] [Full Text] [Related]

  • 20. [Maintenance therapy with 20 mg fluoxetine. Results of an administration study of 1,737 depressed patients].
    Kasper S, Hesselmann B, Wein W.
    Wien Klin Wochenschr; 1997 Mar 28; 109(6):197-201. PubMed ID: 9173668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.